

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. At the time of writing, the benchmark index is down 0.4% to 6,660.3 points.
Four ASX shares that are not letting that hold them back are listed below. Hereâs why they are pushing higher:
Computershare Limited (ASX: CPU)
The Computershare share price is up 3% to $24.27. This appears to have been driven by a broker note out of Ord Minnett. Its analysts have upgraded the administration services companyâs shares to an accumulate rating with a $26.00 price target. The broker believes that rising interest rates will be a positive for Computershare.
Lithium Plus Minerals Ltd (ASX: LPM)
The Lithium Plus share price is up 36% to 40 cents. This morning the lithium explorer advised that its mining management plan for the flagship Bynoe Lithium Project has been approved. As a result, the company has appointed Darwin-based drilling contractor, GeoDrilling, to undertake an initial program of approximately 10,000 metres of Reverse Circulation drilling.
Lynas Rare Earths Ltd (ASX: LYC)
The Lynas share price is up 4.5% to $8.91. The catalyst for this appears to have been a broker note out of Macquarie. This morning it reiterated its outperform rating and $12.80 price target on this rare earths producer’s shares. This was in response to the companyâs update on Tuesday, which revealed that it has been awarded a US$120 million contract by the US government to build a heavy rare earths facility.
ResApp Health Ltd (ASX: RAP)
The ResApp share price is up a further 6% to 17.5 cents. This digital health companyâs shares have been racing higher this week after pharmaceutical giant Pfizer improved its takeover offer. Pfizer agreed to increase its offer from 11.5 cents per share in cash to either 14.6 cents or 20.7 cents per share. The ultimate price will depend on the results of a clinical validation study, which investors appear to believe will be successful.
The post Why Computershare, Lithium Plus, Lynas, and ResApp shares are pushing higher appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of January 12th 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Guess which ASX lithium share surged 56% higher today
- ASX 200 midday update: ResMed’s US$1bn acquisition, tech shares continue to sink
- 3 ASX 200 shares that avoided today’s sell-off
- Here’s why the ResApp share price is rocketing 50% today
- Why Australian Clinical Labs, Lake Resources, PolyNovo, and ResApp are rising
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/aZbQLvB
Leave a Reply